GCLC and neoplasm: To elucidate its regulatory mechanisms, future research will employ transcriptome sequencing to identify potential targets, such as GSH metabolism-related enzymes (e.g., GCLC, GSS) or signaling pathways influencing the tumor immune microenvironment.